Want to join the conversation?
In 2Q17, $APOG had positive free cash flow of $28MM compared to $31MM in 2Q16, with strong earnings and good working capital performance. The current year CapEx is higher as planned, as the company invests mainly in capabilities & productivity across its businesses. $APOG continues to have strong days working capital management with DWC at 45 days.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.